24 February 2018
News and Views
Links and Services
The latest issue of the Alimentary Pharmacology & Therapeutics compares standard- with double-dose proton pump inhibitors for the healing of severe erosive esophagitis.
No randomized controlled trial has compared all European-licensed standard- and double-dose proto
Email this page to a colleague
GastroHep.com is a Blackwell Publishing registered trademark
© 2018 Wiley-Blackwell and GastroHep.com and contributors